CAS: 4332-95-0 - Tyrosine phenylthiohydantoin
Formula:C16H14N2O2S
InChI:InChI=1S/C16H14N2O2S/c19-13-8-6-11(7-9-13)10-14-15(20)18(16(21)17-14)12-4-2-1-3-5-12/h1-9,14,19H,10H2,(H,17,21)
InChI key:InChIKey=LCFDDJINTNHAEQ-UHFFFAOYSA-N
SMILES:O=C1N(C=2C=CC=CC2)C(=S)NC1CC3=CC=C(O)C=C3
- Synonyms:
- 4-Imidazolidinone, 5-[(4-hydroxyphenyl)methyl]-3-phenyl-2-thioxo-
- 5-[(4-Hydroxyphenyl)methyl]-3-phenyl-2-thioxo-4-imidazolidinone
- Hydantoin, 5-(p-hydroxybenzyl)-3-phenyl-2-thio-
- NSC 96434
- PTH-DL-Tyrosine Phenylthiohydantoin-DL-tyrosine
- Phenylthiohydantoin-tyrosine
- Tyrosine phenylthiohydantoin
- Tyrosine, 3-phenyl-2-thiohydantoin
Phenylthiohydantoin-tyrosine
CAS:4332-95-0
Formula:
C16H14N2O2S
Purity:
>98.0%(HPLC)
Color and Shape:
White to Light yellow powder to crystaline
Molecular weight:
298.36
Ref: 3B-P0368
1g | 142.00 € | ||
100mg | 26.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
PTH-TYROSINE
CAS:4332-95-0
Formula:
C16H14N2O2S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
298.3596
- Building Blocks
- Pharmaceutical Standards
- Analytical Volumetric Solutions and Indicators
- Amino Acids (AA)
- See more categories
- Peptides
- Amino Acid Derivatives
- Fmoc Amino Acids
- Active Pharmaceutical Ingredient (API) Related Compounds for Research
- Biochemicals and Reagents
- Heterocycles with Nitrogen (N)
- Heterocyclic Compounds
Ref: IN-DA003U0P
1g | 157.00 € | ||
5g | 488.00 € | ||
100mg | 51.00 € | ||
250mg | 63.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
5-(4-Hydroxybenzyl)-3-phenyl-2-thioxoimidazolidin-4-one
CAS:4332-95-0
Purity:
98%
Molecular weight:
298.3599853515625
Ref: 10-F726898
1g | 128.00 € | ||
5g | 478.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
PTH-tyrosine
CAS:4332-95-0
PTH-tyrosine is a basic protein that is found in the plasma and other body fluids. …
Formula:
C16H14N2O2S
Purity:
Min. 95%
Molecular weight:
298.36 g/mol
Ref: 3D-EAA33295
1g | To inquire | ||
5g | To inquire |
Estimated delivery in United States, on Tuesday 11 Feb 2025